Seminar: GDPR Code of Conduct for Health Research and Implications for FP9

BBMRI-ERIC is hosting a seminar to assess the impact of the GDPR on FP9 health research and examine how the Code of Conduct for Health Research being developed by BBMRI-ERIC and collaborators will address future health challenges. The seminar will take place on 6 November 2017 in Brussels.

Preparations for FP9 (2021-2027) have begun and the European Commission is expected to publish its initial proposal in the first half of 2018. Discussions on the programme’s structure, content, and budget are under way covering sustainability, socio-economic impact, and the use and management of data created by pan-European research infrastructures, including the contribution of these infrastructures to health sciences and research.

The General Data Protection Regulation (GDPR) will apply across the EU from 25 May 2018. Articles 40 and 41 of the GDPR are the primary sources of authority for establishing approved codes of conduct to serve as compliance tools for data controllers and processors.

Following a series of exploratory meetings in 2017, BBMRI-ERIC has launched a forum to develop a GDPR Code of Conduct for Health Research as the means to comply and to contribute to the proper implementation of the GDPR. Through the forum, BBMRI-ERIC is engaging with approximately 80 key stakeholders and a drafting group from across the EU, to outline the GDPR Code of Conduct for Health Research. This code will be vital for enabling and advancing collaborative health research following the application of the GDPR.

The seminar on 6 November 2017 will focus on how the new data protection environment will determine and affect the use of (sensitive) personal data for health sciences in future research collaborations. The seminar will also help participants to understand the policy context for FP9 and how this will be impacted by the GDPR and other regulations, including those covering medical devices and clinical trials. The seminar will also include discussions on how the programme might address biological and medical science research, including the use of sensitive personal data, for the programme to deliver benefits for the EU’s citizens and economy.

The seminar sessions will cover big data and the European Open Science Cloud, GDPR and the Code of Conduct for Health Research, and FP9.

Speakers will include:

Jan-Eric Litton, Senior Advisor, BBRMRI-ERIC;
Michaela Th. Mayrhofer, Chief Policy Officer, BBMRI-ERIC;
Augusto Burgueno Arjona, Head of Unit, European Commission;
Magali Poinot, Advisor to the Executive Director, IMI2;
Brendan Barnes, Director Data protection, IP & Global Health, EFPIA;
Lydia Makaroff, Director, European Cancer Patient Coalition;
Nathalie Bertels, Big Data Value Association.

The seminar will take place on Monday, 6 November 2017, from 10h00 to 16h00 at Science 14, 14b Rue de la Science, Brussels B-1040.

Click here to register.

For further information on the 6 November seminar, please contact:

Tjaša Petročnik, Policy analyst, ISC Intelligence in Science
Email: tjasa.petrocnik@iscintelligence.com
Tel: +32 2 880 36 24